BEAM
Price
$16.83
Change
-$0.39 (-2.26%)
Updated
May 23 closing price
Capitalization
1.69B
79 days until earnings call
CELC
Price
$10.44
Change
-$0.31 (-2.88%)
Updated
May 23 closing price
Capitalization
395.32M
74 days until earnings call
Interact to see
Advertisement

BEAM vs CELC

Header iconBEAM vs CELC Comparison
Open Charts BEAM vs CELCBanner chart's image
Beam Therapeutics
Price$16.83
Change-$0.39 (-2.26%)
Volume$962.38K
Capitalization1.69B
Celcuity
Price$10.44
Change-$0.31 (-2.88%)
Volume$144.76K
Capitalization395.32M
BEAM vs CELC Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CELC commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CELC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (BEAM: $16.83 vs. CELC: $10.44)
Brand notoriety: BEAM and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 41% vs. CELC: 60%
Market capitalization -- BEAM: $1.69B vs. CELC: $395.32M
BEAM [@Biotechnology] is valued at $1.69B. CELC’s [@Biotechnology] market capitalization is $395.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCELC’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and CELC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CELC’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 2 bearish.
  • CELC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both BEAM and CELC are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -5.93% price change this week, while CELC (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CELC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than CELC($395M). CELC YTD gains are higher at: -20.244 vs. BEAM (-32.137). CELC has higher annual earnings (EBITDA): -85.45M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CELC (264M). CELC has less debt than BEAM: CELC (97.2M) vs BEAM (158M). BEAM has higher revenues than CELC: BEAM (63.6M) vs CELC (0).
BEAMCELCBEAM / CELC
Capitalization1.69B395M428%
EBITDA-399.03M-85.45M467%
Gain YTD-32.137-20.244159%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B264M462%
Total Debt158M97.2M163%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCELC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBEIX13.33N/A
N/A
William Blair Emerging Mkts Growth I
JIEMX18.76-0.04
-0.21%
JHancock Equity Income 1
GIUIX36.47-0.10
-0.27%
NAA Mid Growth Institutional
FDTRX184.96-1.25
-0.67%
Franklin DynaTech R6
VIMCX59.34-0.48
-0.80%
Virtus KAR Mid-Cap Core I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.26%
CRSP - BEAM
71%
Closely correlated
-1.79%
NTLA - BEAM
66%
Loosely correlated
-3.17%
RXRX - BEAM
63%
Loosely correlated
-0.37%
VERV - BEAM
58%
Loosely correlated
+3.07%
ABCL - BEAM
58%
Loosely correlated
-1.01%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ATXS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-2.88%
ATXS - CELC
44%
Loosely correlated
N/A
CLDX - CELC
44%
Loosely correlated
+2.01%
ABOS - CELC
44%
Loosely correlated
-1.92%
CCCC - CELC
43%
Loosely correlated
+1.47%
BEAM - CELC
42%
Loosely correlated
-2.26%
More